Publication | Closed Access
A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors
29
Citations
31
References
2019
Year
OncologySolid TumorsMedicineAnti-cancer AgentCancer TreatmentBh3 MimeticPharmacologyRadiation OncologyCancer ResearchCancer Growth
| Year | Citations | |
|---|---|---|
Page 1
Page 1